20×Revenue Growth
HemoTypeSC Global Expansion
01Challenge
HemoTypeSC had been on the market for 5 years with only one global distributor whose performance was stagnant. The distributor was too large to prioritize a low-cost POC test, resulting in minimal sales (<100K quarterly).
02Strategy
Shift from one large global distributor to a network of smaller, motivated regional partners who would prioritize HemoTypeSC as a core revenue driver.
03Execution
- 1Built country-specific distributor networks across India, LATAM, and Africa.
- 2Worked directly with hematologists, pediatricians, KOLs, and SCD advocacy groups.
- 3Conducted in-country visits to Nigeria, Ghana, Kenya, Tanzania, DRC, Mali, Togo, Sierra Leone, Mozambique.
- 4Developed awareness, training, and clinical engagement programs.
04KPIs
- Scaled from <100K to 2M+ quarterly tests
- Expanded into 15+ countries
- Achieved 20× revenue growth
05Outcome
Transformed HemoTypeSC from a stagnant product into a global screening platform adopted by Ministries of Health, NGOs, and clinical networks.
06Tools and Methods
Need Results Like These?
Let's talk about the market you want to open next.